Consumer Defensive
Live Price
Offline$4.65
-15.55% today
1Y Change
-99.73%
Window
Jun 23, 2025 โ Jun 12, 2026
Coverage: 245 bars ยท Jun 23, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
22nd Century Group, Inc. (XXII) is a Consumer Defensive stock with listed on NASDAQ. The stock last traded around $4.64 and down 99.7% across the available one-year price window (Jun 23, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of +48.1%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue +48.1%, EPS 0.0%, free cash flow +46.3% with operating margin -65.8% and ROIC -57.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines XXII price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+48.1% vs +1.7% peer median
Operating Margin
Below sector median
-65.8% vs +6.6% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 15, 2026, but the surprise data is still limited.
The setup is mixed rather than one-directional
Revenue is +48.1% and EPS is 0.0%, while operating margin sits near -65.8%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -11.2% over the next 5 trading days and finished higher after 0 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 15, 2026 | โ | +6.5% | -5.1% | โ |
2026 Mar 26, 2026 | -180.5% | -18.0% | -23.0% | -43.5% |
2025 Nov 4, 2025 | +93.7% | -1.6% | -5.4% | -20.9% |
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
XXII
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
XXII Max Drawdown
-99.75%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for XXII and SPY.

Company Overview
22nd Century Group, Inc.
NASDAQ Capital Market
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.